CURRENT NEWS

• 28.02.2020
  ORYZON Committed to Rare Diseases with Its Research in Acute Myeloid Leukemia
• 27.02.2020
  Clarivate Reports Q4 and Full Year 2019 Results
• 27.02.2020
  Moffitt Cancer Center Named a Best and Brightest Company to Work for in the Nation
• 27.02.2020
  Pre-Operative Immunotherapy Shows Promise in Oral Cancers
• 27.02.2020
  Stericycle, Inc. Reports Results for the Fourth Quarter 2019, Provides 2020 Guidance
• 27.02.2020
  New Study Shows Predictive Immune Modeling From Cofactor Genomics Is Superior to PD-L1 Assays in Predicting Patient Response to Anti-Pd-1 Therapy
• 27.02.2020
  DNA Script Presents New Data Demonstrating the Feasibility of the Company's Enzymatic Synthesis Technology
• 27.02.2020
  zPREDICTA Enters Strategic Collaboration With LabCorp to Advance the Use of 3D Cell Cultures in Research and Drug Development
• 27.02.2020
  Synteract Launches Rare Disease Institute: An Innovational Program Specifically Focused on Rare Diseases
• 27.02.2020
  NuProbe Announces Licensing Deal With Oxford Nanopore
• 27.02.2020
  Boehringer Ingelheim Enters Discovery Stage Collaboration With Trutino Biosciences to Grow Its Cancer Immunology Portfolio With Novel Cytokine Platform
• 27.02.2020
  Ibex Obtains CE-IVD Mark for AI-powered Cancer Detection
• 27.02.2020
  ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin Gel sNDA to FDA in March 2020
• 27.02.2020
  Angle PLC Announces Parsortix Outperforms Other CTC Systems in RCC
• 27.02.2020
  Catalent Announces Supplying Blueprint Medicines' Precision Therapy AYVAKIT (Avapritinib)
• 27.02.2020
  NantHealth's Cancer Therapy Pre-Authorization Platform Eviti Connect Starts 2020 Strong with Two Expanded Programs
• 27.02.2020
  Co-Diagnostics Announces $4.2 Million Registered Direct Offering Priced At-The-Market
• 27.02.2020
  Harbour BioMed Receives U.S. FDA IND Approval for Phase 2 Clinical Trial and Orphan Drug Designation for Anti-Pd-L1 Monoclonal Antibody, HBM9167
• 27.02.2020
  Roche to Invest in Cape Town Site to Accommodate Rapid Growth and Future Expansion for Its Diagnostics Business
• 27.02.2020
  Perrigo Company Plc Reports Fourth Quarter & Fiscal Year 2019 Financial Results

Records per page:

Page

Total: 16401 records.